These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3490260)

  • 21. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.
    Masson C; Angles-Cano E
    Biochem J; 1988 Nov; 256(1):237-44. PubMed ID: 3146972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator.
    Campbell IK; Piccoli DS; Butler DM; Singleton DK; Hamilton JA
    Biochim Biophys Acta; 1988 Nov; 967(2):183-94. PubMed ID: 3142527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.
    Hanss M; Collen D
    J Lab Clin Med; 1987 Jan; 109(1):97-104. PubMed ID: 3098881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.
    Loskutoff DJ; Roegner K; Erickson LA; Schleef RR; Huttenlocher A; Coleman PL; Gelehrter TD
    Thromb Haemost; 1986 Feb; 55(1):8-11. PubMed ID: 3486492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
    Levin EG; Loskutoff DJ
    J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
    Hekman CM; Loskutoff DJ
    J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
    Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
    Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin-1.
    Rogister B; Leprince P; Delree P; Van Damme J; Billiau A; Moonen G
    Glia; 1990; 3(4):252-7. PubMed ID: 2168862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of tissue plasminogen activator to cultured human endothelial cells.
    Hajjar KA; Hamel NM; Harpel PC; Nachman RL
    J Clin Invest; 1987 Dec; 80(6):1712-9. PubMed ID: 3119664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo.
    Kooistra T; Opdenberg JP; Toet K; Hendriks HF; van den Hoogen RM; Emeis JJ
    Thromb Haemost; 1991 May; 65(5):565-72. PubMed ID: 1908141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1-mediated stimulation of prostaglandin E production is without effect on plasminogen activator activity in human granulosa lutein cell cultures.
    Hurwitz A; Lavy Y; Finci-Yeheskel Z; Milwidsky A; Shimonovitz S; Yagel S; Adashi EY; Laufer N; Mayer M
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3018-24. PubMed ID: 7559890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.
    Bevilacqua MP; Schleef RR; Gimbrone MA; Loskutoff DJ
    J Clin Invest; 1986 Aug; 78(2):587-91. PubMed ID: 3090105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
    Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
    Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP.
    Francis RB; Neely S
    Biochim Biophys Acta; 1989 Jul; 1012(2):207-13. PubMed ID: 2545266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
    J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte urokinase expression: modulation by interleukins.
    Gyetko MR; Wilkinson CC; Sitrin RG
    J Leukoc Biol; 1993 May; 53(5):598-601. PubMed ID: 8501398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin.
    Grant MB; Guay C
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):53-64. PubMed ID: 1702773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.